Plain-English translation of NCT06185556 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing and comparing two newer treatment options for people with colorectal cancer that has spread to the liver in locations near important blood vessels or bile ducts—places where traditional surgery or heat-based treatments are too risky. One approach uses electrical pulses to destroy tumor cells (irreversible electroporation, or IRE), while the other uses precise, targeted radiation (stereotactic body radiotherapy, or SBRT). The study will determine which treatment works better at controlling the cancer and has fewer side effects.
Currently, there is no clear best treatment for these anatomically challenging liver tumors that cannot be removed surgically or treated with heat-based methods. This trial exists to compare these two newer, less invasive options and help doctors choose the safest and most effective approach for future patients.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to receive either the electrical pulse treatment or the targeted radiation treatment. The study involves detailed imaging scans before your procedure, the treatment itself (which is less invasive than traditional surgery), and follow-up visits to monitor how well the treatment is working and track any side effects. Researchers will check on you at regular intervals over 2 years to assess how your tumors respond and measure your overall health outcomes.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
Netherlands